# ArriVent BioPharma, Inc.: Form 8-K, filed Mar 5, 2026

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: 8-K
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 5, 2026, 16:11 ET
- Period: 2026-03-05
- Accession: 0001104659-26-024112
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465926024112/avbp-20260305x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465926024112/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465926024112/avbp-20260305x8k.htm

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-024112. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.